Since cancer rarely results from a single mutation and, like other cancers, ES/PNET cells contain other mutations (e.g. p53), understanding the precise mechanism by which the EWS/FLI-1 protein results in transformation will be important in the development of effective therapies for this condition. This evidence concerns the gene TP53 and cancer.